- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-19-0017277

Megmento Pharmaceuticals Private Limited
About Megmento Pharmaceuticals Private Limited
Data last updated:
Megmento Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24299OR2021PTC035944. Its GSTIN is 21AAOCM4348N1Z2 (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anjali Agarwalla and Prabhat Kumar Choubey.
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 101 Metro Emerald P.S – Laxmi Sagar, Bhubaneswar, Odisha, India – 751006.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.1 Cr, a growth of 97% compared to the previous year. For the same year it recorded a net profit of ₹10.4 Lakh (net margin 5%) and EBITDA of ₹38.5 Lakh (EBITDA margin 18.4%).
The company has about 7 employees on its provident fund (EPFO) records.
Megmento Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0017277).
Company details
Recognitions & Rankings of Megmento Pharmaceuticals
Contact details
Megmento Pharmaceuticals Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – 101 Metro Emerald P.S – Laxmi Sagar, Bhubaneswar, Odisha, India – 751006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Megmento Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Megmento Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Megmento Pharmaceuticals Private Limited, buy the company report.
Financials of Megmento Pharmaceuticals Private Limited
FY 2025 filings availableMegmento Pharmaceuticals Private Limited reported revenue of ₹2.1 Cr (up 97% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 97% in the latest year. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹38.5 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹10.4 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 18.4% | |||
| Net Profit Margin | 5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Megmento Pharmaceuticals Private Limited, buy the company report.
Board of directors of Megmento Pharmaceuticals Private Limited
Megmento Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjali Agarwalla | Director | 19 Mar 2021 | 5 Years 8 Months | Current |
| Prabhat Kumar Choubey Also directs: Foodiversal Studios LLP, Exceptional Property 2Wo LLP, Exceptional Property 1Ne LLP and 4 more | Director | 19 Mar 2021 | 5 Years 8 Months | Current |
| Karishma Sharma Also directs: Foodiversal Studios LLP | Additional Director | 09 Nov 2023 | 3 Years 0 Months | Current |
Peer comparison
Megmento Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jupiven Pharmaceuticals Private Limited | ₹2.11 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Megmento Pharmaceuticals Private Limitedthis company | ₹2.1 Cr (FY 2024) | ₹10.4 Lakh | 5% | 97.0% | 7 | Bhubaneswar, Odisha, India |
| Proneness Pharmaceuticals Private Limited | ₹2.09 Cr (FY 2025) | 38.0% | Lucknow, Uttar Pradesh, India | |||
| Knight Pharmaceuticals Private Limited | ₹2.09 Cr (FY 2025) | 1.0% | Virar, Maharashtra, India | |||
| Deepodaya Pharmaceuticals Private Limited | ₹2.08 Cr (FY 2025) | -51.0% | Lucknow, Uttar Pradesh, India | |||
| Enma Pharmaceuticals Private Limited | ₹2.08 Cr (FY 2025) | 8.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Megmento Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Megmento Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Megmento Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Megmento Pharmaceuticals Private Limited has a workforce of 7 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 7 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Megmento Pharmaceuticals Private Limited, buy the company report.
GST
Megmento Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAOCM4348N1Z2 | Odisha | Active | 17 Nov 2021 |
To see the full GST registrations and return filing status of Megmento Pharmaceuticals Private Limited, buy the company report.
Recent activity
Megmento Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Karishma Sharma was appointed as Additional Director on 09 Nov 2023.
Frequently asked questions
Megmento Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 March 2021 (5+ years old) and is registered under CIN U24299OR2021PTC035944.
Megmento Pharmaceuticals has 3 current directors:
- Anjali Agarwalla - Director
- Prabhat Kumar Choubey - Director
- Karishma Sharma - Additional Director
The latest financial statements of Megmento Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Megmento Pharmaceuticals is 21AAOCM4348N1Z2, registered in Odisha.
The CIN (Corporate Identification Number) of Megmento Pharmaceuticals is U24299OR2021PTC035944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Megmento Pharmaceuticals was incorporated on 19 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Megmento Pharmaceuticals by revenue are Jupiven Pharmaceuticals Private Limited, Proneness Pharmaceuticals Private Limited, Knight Pharmaceuticals Private Limited, Deepodaya Pharmaceuticals Private Limited, Enma Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Karishma Sharma was appointed as Additional Director on 09 Nov 2023. Anjali Agarwalla was appointed as Director on 19 Mar 2021. Prabhat Kumar Choubey was appointed as Director on 19 Mar 2021.
Yes, Megmento Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0017277).
The registered office of Megmento Pharmaceuticals is at Plot No – 101 Metro Emerald P.S – Laxmi Sagar, Bhubaneswar, Odisha, India – 751006.
Megmento Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

